NEW YORK --(BUSINESS WIRE)--Aug. 7, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio , Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the Wedbush PacGrow Healthcare Conference in New York on Wednesday, August 14, 2019

- Company Continues to Expand its Gene Therapy Portfolio with the Addition of miniUSH2A Program - - Company to Host First Gene Therapy R&D Investor Day on September 13, 2019 - - Conference Call and Webcast Today, August 1, 2019 , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)--Aug.

NEW YORK --(BUSINESS WIRE)--Jul. 25, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2019 financial and operating results on Thursday, August 1, 2019 . Following the announcement, IVERIC bio’s management team will host a live conference call and webcast